Brief: First Wave BioPharma Announces Initial Clinical Sites For Its Phase 2 Trial Of Enhanced Microgranule Delivery Formulation Of Adrulipase

GridAI Technologies

05/12/2022 12:03

Dec 5 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA ANNOUNCES INITIAL CLINICAL SITES FOR
ITS
PHASE 2 TRIAL OF ENHANCED MICROGRANULE DELIVERY FORMULATION OF
ADRULIPASE
    * FIRST WAVE BIOPHARMA - BASED ON ANTICIPATED REGULATORY AND
CLINICAL TRIAL ACTIVITIES, EXPECTS TO REPORT TOPLINE DATA FROM
PHASE 2 TRIAL BY MID-2023

Source text for Eikon:  ID:nGNX3Dw1W2 
Further company coverage:  FWBI.O